DK2686006T3 - Sammensætning omfattende diaminoxidase til forebyggelse af tømmermændssymptomer - Google Patents

Sammensætning omfattende diaminoxidase til forebyggelse af tømmermændssymptomer Download PDF

Info

Publication number
DK2686006T3
DK2686006T3 DK12711464.3T DK12711464T DK2686006T3 DK 2686006 T3 DK2686006 T3 DK 2686006T3 DK 12711464 T DK12711464 T DK 12711464T DK 2686006 T3 DK2686006 T3 DK 2686006T3
Authority
DK
Denmark
Prior art keywords
dao
composition
histamine
symptoms
hangover
Prior art date
Application number
DK12711464.3T
Other languages
English (en)
Other versions
DK2686006T4 (da
Inventor
Riu Carlos Duelo
Riu Juan José Duelo
Original Assignee
Dr Healthcare España S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45922735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2686006(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr Healthcare España S L filed Critical Dr Healthcare España S L
Application granted granted Critical
Publication of DK2686006T3 publication Critical patent/DK2686006T3/da
Publication of DK2686006T4 publication Critical patent/DK2686006T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03006—Amine oxidase (copper-containing)(1.4.3.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03022—Diamine oxidase (1.4.3.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Alcoholic Beverages (AREA)

Claims (8)

1. Sammensætning omfattende diaminoxidase (DAO) til anvendelse ved forebyggelse af tømmermændssymptomer fremkaldt ved indtagelse af alkoholiske drikke.
2. Sammensætning ifølge krav 1, hvor sammensætningen indgives oralt i form af tabletter, kapsler eller sachets.
3. Sammensætning til anvendelse ifølge krav 1 og 2, hvor DAO i sammensætningen indgives i en dosis på mellem 0,1 og 50 mg.
4. Sammensætning til anvendelse ifølge krav 1 til 3, hvor sammensætningen også indeholder koffein.
5. Sammensætning til anvendelse ifølge krav 1 til 4, hvor koffeinen indgives i en dosis på mellem 1 og 100 mg.
6. Sammensætning til anvendelse ifølge krav 1 til 5, hvor dosisformerne har gastrisk beskyttelse.
7. Sammensætning til anvendelse ifølge krav 1 til 6, hvor DAO anvendes i fri form, i pulver, lyofiliseret pulver, mikrokapsler, nanokapsler eller liposomer.
8. Sammensætning til anvendelse ifølge krav 1 til 7, hvor sammensætningen indgives mellem 1 time og 15 minutter før påbegyndelse af indtagelse af alkoholiske drikke.
DK12711464.3T 2011-03-18 2012-03-16 Sammensætning omfattende diaminoxidase til forebyggelse af tømmermændssymptomer DK2686006T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201130380A ES2388515B1 (es) 2011-03-18 2011-03-18 Uso de la diaminooxidasa para la prevención de los síntomas de la resaca.
PCT/IB2012/051275 WO2012127391A1 (en) 2011-03-18 2012-03-16 Composition comprising diamine oxidase for the prevention of hangover symptoms

Publications (2)

Publication Number Publication Date
DK2686006T3 true DK2686006T3 (da) 2017-03-13
DK2686006T4 DK2686006T4 (da) 2020-05-18

Family

ID=45922735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12711464.3T DK2686006T4 (da) 2011-03-18 2012-03-16 Sammensætning omfattende diaminoxidase til forebyggelse af tømmermændssymptomer

Country Status (13)

Country Link
US (1) US20130344136A1 (da)
EP (1) EP2686006B2 (da)
CN (1) CN103429257A (da)
BR (1) BR112013023710A2 (da)
CO (1) CO6801745A2 (da)
DK (1) DK2686006T4 (da)
ES (2) ES2388515B1 (da)
HU (1) HUE033445T2 (da)
MX (1) MX346159B (da)
PL (1) PL2686006T5 (da)
PT (1) PT2686006T (da)
RU (1) RU2627128C2 (da)
WO (1) WO2012127391A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN105246635B (zh) 2013-02-15 2020-06-23 马修·法甘 用于使用龙门式板材切割机来处理包括通用梁的所有长钢材的等离子体机器的方法和系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319540D0 (en) 1983-07-20 1983-08-24 Bovril Ltd Amine removal
GB8325627D0 (en) 1983-09-24 1983-10-26 Scras Therapeutic compositions
US4725540A (en) 1984-07-09 1988-02-16 Emil Underberg Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
RU2143211C1 (ru) * 1999-04-08 1999-12-27 Общество с ограниченной ответственностью "Производственно-торговое предприятие "Медтехника" Биологически активная пищевая добавка для алкогольных напитков
IT1317067B1 (it) 2000-11-29 2003-05-26 Univ Roma Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico.
US7063865B2 (en) * 2002-05-10 2006-06-20 Jeremy Park Jones Composition and method for substantially reducing the deleterious effects of alcohol on the body
AT502098B8 (de) * 2004-07-07 2007-06-15 Albert Dr Missbichler Diaminooxidase-hältige zusammensetzung
KR101324076B1 (ko) * 2005-09-22 2013-10-31 유키지루시 메그밀크 가부시키가이샤 스핑고미엘린 함유 의약, 음식품 또는 사료

Also Published As

Publication number Publication date
ES2618930T3 (es) 2017-06-22
PL2686006T3 (pl) 2017-07-31
EP2686006B2 (en) 2020-02-19
US20130344136A1 (en) 2013-12-26
EP2686006B1 (en) 2016-12-14
HUE033445T2 (en) 2017-11-28
ES2388515B1 (es) 2013-10-01
CO6801745A2 (es) 2013-11-29
ES2388515A1 (es) 2012-10-16
DK2686006T4 (da) 2020-05-18
EP2686006A1 (en) 2014-01-22
MX2013010694A (es) 2013-10-03
MX346159B (es) 2017-03-09
BR112013023710A2 (pt) 2016-12-13
RU2627128C2 (ru) 2017-08-03
WO2012127391A1 (en) 2012-09-27
RU2013144967A (ru) 2015-04-27
CN103429257A (zh) 2013-12-04
ES2618930T5 (es) 2020-11-04
PL2686006T5 (pl) 2020-07-13
PT2686006T (pt) 2017-03-20

Similar Documents

Publication Publication Date Title
Wöhrl et al. Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine.
EP2315582B1 (en) Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20100247489A1 (en) Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems
KR102107387B1 (ko) 흑삼 추출물을 함유하는 숙취해소용 음료 조성물
AU2005259167B2 (en) Diaminooxidase-containing pharmaceutical compositions
DK2686006T3 (da) Sammensætning omfattende diaminoxidase til forebyggelse af tømmermændssymptomer
US20220143151A1 (en) Functional foods comprising diamine oxidase and uses thereof
AU2023246874A1 (en) Alcohol degrading compositions and uses thereof
JP2002265365A (ja) 好中球機能抑制剤
RU2660344C2 (ru) Диаминоксидаза для применения в лечении или предупреждении синдрома дефицита внимания с гиперактивностью (сдвг)
KR20170052688A (ko) 알코올 홍조 및 알코올-유발성 과민 반응의 치료 및 예방을 위한 제제
EP2686004B1 (en) Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
CN110935002A (zh) 具有降血压功效的组合物及其应用
US20170020993A1 (en) Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
CN108434160A (zh) N-乙酰-d-氨基葡萄糖盐在制备防治失眠药物及保健品中的应用及药物